Maxygen Inc.
This article was originally published in Start Up
Executive Summary
Combinatorial Biology. Maxygen, founded by Alejandro Zaffaroni, PhD, is selecting randomly reassembled fragments of DNA for specific properties of the enzymes they produce. Glaxo Wellcome owns more than half of the equity in Maxygen.
You may also be interested in...
polyGenomics Inc.
PolyGenomics was spun-out of Yale University to develop a genetic amplification technology in the search for genes implicated in psychiatric illnesses.
Oxagen Ltd.
Oxagen's goal is to use large familial clinical groups and sample banks to identify disease genes through agreements with three groups of academic clinical investigators, located throughout Europe.
No More Ouch! Vaccine Delivery is Changing
Since the mid-1950's getting "shots" has been a source of childhood terror. Now, small companies are looking at ways to deliver vaccines through the oral or nasal mucosa, or using needle-free skin delivery systems to take advantage of immune cells within the skin.